Cargando…
Association of Drug Rebates and Competition With Out-of-Pocket Coinsurance in Medicare Part D, 2014 to 2018
IMPORTANCE: Prior research has documented the increase in prescription drug rebates and the coincident increase in out-of-pocket burden for patients paying coinsurance tied to list prices. OBJECTIVE: To describe the out-of-pocket burden on patients with coinsurance and assess its association with ph...
Autores principales: | Lakdawalla, Darius, Li, Meng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100863/ https://www.ncbi.nlm.nih.gov/pubmed/33950205 http://dx.doi.org/10.1001/jamanetworkopen.2021.9030 |
Ejemplares similares
-
Association of Branded Prescription Drug Rebate Size and Patient Out-of-Pocket Costs in a Nationally Representative Sample, 2007-2018
por: Yeung, Kai, et al.
Publicado: (2021) -
Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance
por: DiStefano, Michael J., et al.
Publicado: (2023) -
Assessment of Behavioral Health Services Use Among Low-Income Medicare Beneficiaries After Reductions in Coinsurance Fees
por: Fung, Vicki, et al.
Publicado: (2020) -
Impact of list price changes on out-of-pocket costs and adherence in four high-rebate specialty drugs
por: Wong, William Bruce, et al.
Publicado: (2023) -
Premium Rebates and the Quiet Consensus on Market Reform for Medicare
por: Feldman, Roger, et al.
Publicado: (2001)